Facility investments from Amcor and Pluristem, Beanne Chemical falls foul of FDA inspectors, Novozymes acquisition plus a green chemistry app.
Australian company Amcor looks set to join the healthcare packaging giants via a $2 billion deal to purchase the pharmaceutical, …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

